Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/25/13
End: 11/16/16
Due: 11/16/17
Phase: N/A
Priority: Normal
Start: 11/04/14
End: 07/11/16
Due: 07/11/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL | NCT01874288 | Alopexx Oncology, LLC | user2@example.com | None | 2013-11-25 | 2016-11-16 | 2017-11-16 | - | - | 2025-07-14 |
| Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL | NCT02151903 | Alopexx Oncology, LLC | user2@example.com | None | 2014-11-04 | 2016-07-11 | 2017-07-11 | - | - | 2025-07-14 |